ASAM Quality and Science Committee Updates
ASAM’s New Terminology and Definitions (TAD) Subcommittee Convenes
ASAM’s Quality Improvement Council (QIC) has convened a new subcommittee called the Terminology and Definitions (TAD) Subcommittee. Chaired by Michael P. Frost, MD, FASAM, FACP, the subcommittee is tasked with making recommendations to the QIC on standard definitions and terminology use guidelines across all ASAM policies and publications. More specifically, they will prioritize definitions that need updating or development, draft proposed definitions, propose guidelines for terminology usage, and synchronize definitions in all ASAM policies and publications, including the ASAM Criteria. The TAD subcommittee had its kickoff call on December 9, 2020 to build an understanding of the project background, review the timeline for 2021, and discuss upcoming tasks and deliverables.
ASAM’s New Clinical Practice Guideline (CPG) Oversight and Methodology Subcommittee Convenes
ASAM’s Quality Improvement Council (QIC) has convened a new subcommittee called the Clinical Practice Guideline (CPG) Oversight and Methodology Subcommittee. Chaired by Melissa B. Weimer, DO, MCR, FASAM, the subcommittee is tasked with providing oversight to the development, implementation, education, and communication of CPGs. More specifically, they will establish a methodology for the development of CPGs, a topic selection process, a CPG strategic plan, and a methodology for how to manage stakeholder’s involvement. The CPG Oversight and Methodology Subcommittee had its kickoff call on December 2, 2020 to build an understanding of the project background, review the timeline for 2021, and discuss upcoming tasks and deliverables.
ASAM Partners with NCCHC to Develop New Guideline
ASAM will be working in partnership with the National Commission on Correctional Health Care (NCCHC) to develop clinical guidelines and protocols for withdrawal management in jail-based settings. This work is being funded by a grant from the Bureau of Justice Assistance. These guidelines will be developed using the RAND/UCLA Appropriateness Method (RAM)—a process that combines scientific evidence and clinical knowledge to determine the appropriateness of a set of clinical procedures. ASAM’s Quality Improvement Council (QIC) will provide oversight for guideline development. The QIC will work with NCCHC to appoint a Guideline Committee to participate throughout the development process, rate treatment scenarios, and assist in writing. The project is anticipated to be completed by September 2021.